Additionally, the decreased expression of sirtuin 3 (SIRT3) in lung cancer tissues and serum samples could be a promising biomarker for diagnosis with a sensitivity of 86.4%, a specificity of 94%, and a cutoff value of 3.12 [109,110]. This evidence concerns the gene SIRT3 and lung carcinoma.